MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Drug-induced parkinsonism(DIP)"

  • 2026 International Congress

    Parkinsonism in B-Cell Maturation Antigen-Targeting CAR-T Cell Cancer Therapies

    A. Zolin, V. Gao, D. Riegel, C. Snajdr-Trinch, B. Santomasso, R. Magge, S. Wesley, H. Danish, H. Sarva, H. Ooi, A. Yoo (New York, USA)

    Objective: Describe parkinsonism after B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor (CAR) T-cell therapy for treatment of multiple myeloma. Background: BCMA-targeted CART-cell therapy effectively treats…
  • 2025 International Congress

    40,000 Instrumented Timed-up-and-go Tests – Standardization is within Reach

    Z. Yekutieli, P. Lewitt (Tel Aviv, Israel)

    Objective: Timed-up-and-go (TUG) is a standard test in neurological assessment. TUG completion time is currently the only quantitative result reported and matched against age and…
  • 2025 International Congress

    Drug-induced parkinsonism with resting tremor

    M. Nomoto, A. Watanabe (Imabari Ehime, Japan)

    Objective: Resting tremor might be developed by long-term treatment of dopamine receptor antagonists in cases of drug-induced parkinsonism Background: Resting tremor is one of the…
  • 2025 International Congress

    Parkinsonism following Chronic Disulfiram Overdose

    S. Ray, V. Kamath, B. Bairy (Bangalore, India)

    Objective: To describe the effect of chronic intake of disulfiram Background: Background- Drug induced parkinsonism is one of the commonest causes of non-degenerative parkinsonism. Typical…
  • 2025 International Congress

    Drug-induced Parkinsonism Mimicking Parkinson´s Disease in Patients Treated with Flunarizine for Migraine

    N. Guragain, R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari (Kathmandu, Nepal)

    Objective: To understand the pattern of movement disorders caused by migraine prophylactic medicine such as flunarizine. Background: Migraine prophylactic treatments are usually taken for short…
  • 2025 International Congress

    Neuroprotective Role of Diosgenin-Loaded Lipid Nanoparticles for Parkinson’s Disease: Pharmacokinetic and Pharmacodynamic Insights

    R. Rajput, S. Verma (Agra, India)

    Objective: To develop, optimize, and evaluate diosgenin-loaded solid lipid nanoparticles (DG-SLNs) and nanostructured lipid carriers (DG-NLCs) incorporated into hydrogel formulations (DG-SLN-C and DG-NLC-C) for improved…
  • 2025 International Congress

    Cerebellar Syndrome and Parkinsonism Associated with Acquired Hepatocerebral Degeneration with Unusual Findings on Neuroimaging.

    R. Sanjinez, J. Bestoso (Buenos Aires, Argentina)

    Objective: To present a clinical case of cerebellar syndrome and parkinsonism linked to acquired hepatocerebral degeneration exhibiting atypical radiological abnormalities. Background: Acquired hepatocerebral degeneration (AHCD)…
  • 2025 International Congress

    Carvacrol modulates rotenone-induced Nigrostriatal Neuronal Death and Angiogenesis via targeting AMPK/FOXO3 transcription factor O3 Signaling cascade

    D. Singh (Allahabad, India)

    Objective: With an eye toward its effects on striatal angiogenesis and the AMPK/ FOXO3 transcription factor O3 pathway, this work attempts to investigate the neuroprotective…
  • 2024 International Congress

    Quantitative EEG Analysis for Comparing Drug-Induced Parkinsonism and Parkinson’s Disease

    S. Seo, S. Kim, SP. Kim, J. Kim, D. Chung, SY. Kang (Ulsan, Republic of Korea)

    Objective: To know whether EEG could be a neural indicator that distinguish between Drug-induced parkinsonism (DIP) and Parkinson’s disease (PD). Background: DIP is the second…
  • 2024 International Congress

    Prevalence of Movement Disorders in Epilepsy Patients Taking Antiepileptics Drugs in a Tertiary Care Teaching Hospital in Nepal.

    N. Guragain, P. Gyawanli, A. Mudvari, P. Prasad, R. Ghimire, B. Gajurel, R. Ojha (Kathmandu, Nepal)

    Objective: To assess the prevalence of movement disorders in epilepsy patients taking antiepileptics drugs. Background: A prospective longitudinal observational study was conducted for one year…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 11
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley